European Growth Leaders 2026

Annual ranking data providerLSEG WorkspaceUsed with permission · acknowledgements

An independent research observatory tracking Europe’s listed growth companies.

By Francesco Castellaneta

← All companies

Annual rank65

Sweden · Healthcare

Medicover

Provides healthcare services based on integrated-care and fee-for-service models, alongside laboratory testing across major clinical-pathology areas.

+58%revenue growth
FY2022–FY2025
+541%net-income growth
FY2022–FY2025
+62%stock return
FY2022–FY2025
+22%2026 stock return
current context only

Company profile · 2026 edition

Care networks, laboratories and patient access

Medicover combines patient care with laboratory diagnostics across Europe and India. Healthcare Services spans employer-funded subscriptions, clinics, hospitals, dentistry, fertility care, mental-health centres and wellbeing facilities. Diagnostic Services links laboratories and local collection points in a hub-and-spoke network, offering routine testing alongside genetics and histopathology. The result is a group that both delivers care and supplies information used along the clinical pathway. On 6 August 2026, Medicover and local partners agreed to sell Medicover Hospitals India; at that date, the hospital business was still reported within the group and the conditional sale had not closed.

2026 edition record. This historical profile was prepared for the 2026 edition and can include developments after FY2025. Dated plans retain their stated status. Later editions may add analysis; factual corrections and link maintenance remain possible.

Healthcare services

From an employee benefit to a broad care network

Medicover's original model finances and delivers prepaid healthcare for employers and individuals. It sits beside fee-for-service and publicly funded care across medical clinics, hospitals, dental practices, fertility clinics, mental-health centres, pharmacies, optical outlets and gyms.

Laboratory diagnostics

When tissue slides become shareable data

Diagnostic Services offers over 12,000 parameters. Its hub-and-spoke system moves samples to core and specialist laboratories; in histopathology, glass slides can instead be scanned and shared. Medicover's digital platform connects more than 100 pathologists with core laboratories in Serbia, Poland and Romania, allowing difficult tissue cases and second opinions to travel electronically. In Q2 2026, Synevo Ukraine launched what the group calls the country's first AI-assisted cytology screening, combining cytologist expertise with advanced imaging algorithms; the source describes assistance, not autonomous diagnosis or decision governance.

Geography and brands

Local names connect a multi-market diagnostic footprint

The diagnostic network operates in fifteen European markets, with brands adapted to local systems: Synevo in Romania and Ukraine, IMD and specialist clinic networks in Germany, and beo-lab in Serbia. Healthcare Services has major operations in Poland and Romania; the August 2026 source record also included Medicover Hospitals India. On 6 August 2026, Medicover and local partners agreed to sell 100% of MHI to KKR-managed funds; the sale was subject to approvals and was expected to close in Q4 2026. The disclosed transaction concerns the MHI hospital platform, so it is not presented as a completed or group-wide India exit.

Operating model and origin

Digital access builds on a Warsaw subscription idea

Medicover uses online ordering, patient applications, remote consultations and laboratory automation to widen access and raise utilisation. Its strategy combines service expansion, laboratory optimisation, technology and selective acquisitions. The origin is memorable: the first Warsaw clinic opened in 1995, and an early logo was sketched on a napkin during a flight to Poland.

Annual record

Ranking history

Future editions add rows; they do not rewrite the 2026 record.

EditionMeasurement periodRankRevenue growthNet-income growthStock return
2026FY2022–FY202565+58%+541%+62%